A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards DENDRITIC CELLS and T-LYMPHOCYTES.
Chemokine Ccl21 has been studied across 16 research domains including 🔬 Oncology, 🛡️ Immunity, 🔬 Inflammation, ✨ Skin & Hair, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 35% of studies addressing this area.
This evidence profile for Chemokine Ccl21 is generated deterministically from 184 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.